Targeted ultrasound therapy offers a less invasive prostate cancer treatment designed to minimize disruption to daily life.
Vanquish uses ultrasound, transurethral and electromagnetically guided thermotherapy to ablate prostate tissue.
MINNEAPOLIS, March 5, 2026 /PRNewswire/ — Francis Medical, Inc., a privately held medical device company, announced today the successful completion of the first commercial (non-clinical trial) ...
Profound Medical Corp. (NASDAQ:PROF) Q4 2025 Earnings Call Transcript March 6, 2026 Operator: Good day, and thank you for ...
King Faisal Specialist Hospital and Research Centre (KFSH) in Riyadh has successfully introduced a pioneering high-intensity ...
TORONTO, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage innovator in interventional MRI (“iMRI”) procedures, is ...
Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative interventional MRI (“iMRI”) procedures, ...
Global Urology Imaging Systems Market OverviewThe global urology imaging systems market is expected to register steady growth ...
Top surgeon Henry Woo has spent plenty of time treating patients struggling with enlarged prostates — so when he started ...
The methods of diagnosing and treating localised prostate cancer has changed significantly in the last two decades.
My daughter, the second her eyes open, without a care for anyone sleeping or what time it might be, right when the rosy ...
In 2025, adults aged 25-34 FAIR Health Consumer, while adults 65 and older (the largest user group in 2024) remained a high proportion of users. FAIR Health Consumer (fairhealthconsumer.org) is FAIR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results